Bixiye
P53-23 Reimbursement Changes for Dental Providers, Effective October 1, 2023
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1771 - 1780 ee natiijooyinka 3289
Bixiye
P54-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P55-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective September 4, 2023 and October 2, 2023
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
P56-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2023
Bixiye
QP65-23 New Medical Coding Pattern Education Program
Taariikhda dhaqangalka Barnaamijka: Jul 26, 2023
Bixiye
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023
Bixiye
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Taariikhda dhaqangalka Barnaamijka: Jul 12, 2023